Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115642315 | 11564231 | 5 | F | 20150715 | 20160920 | 20150928 | 20160923 | EXP | US-GLAXOSMITHKLINE-US2015GSK138022 | GLAXOSMITHKLINE | 76.99 | YR | M | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115642315 | 11564231 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 5ZP1175 | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
| 115642315 | 11564231 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | 5ZP1175 | 21077 | 2 | DF | INHALATION POWDER | BID | ||||
| 115642315 | 11564231 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 21077 | INHALATION POWDER | ||||||||||
| 115642315 | 11564231 | 4 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 115642315 | 11564231 | 5 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 115642315 | 11564231 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | U | 0 | |||||||||||
| 115642315 | 11564231 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | U | 0 | |||||||||||
| 115642315 | 11564231 | 8 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115642315 | 11564231 | 1 | Chronic obstructive pulmonary disease |
| 115642315 | 11564231 | 2 | Asthma |
| 115642315 | 11564231 | 3 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115642315 | 11564231 | HO |
| 115642315 | 11564231 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115642315 | 11564231 | Choking | |
| 115642315 | 11564231 | Cough | |
| 115642315 | 11564231 | Hernia repair | |
| 115642315 | 11564231 | Product quality issue | |
| 115642315 | 11564231 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115642315 | 11564231 | 1 | 2012 | 0 |